Top Markets
Coin of the day
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Hisse Senetlerindeki Sıralama #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Hisse Fiyatı
$0.04082105
Son senkronizasyon: 2024-08-12
Piyasa Değeri
$39.09K
Değişim (1 gün)
-19.83%
Değişim (1 yıl)
0.00%
Ülke
GB
Ticaret Destiny Pharma plc (DEST)

Kategori

Destiny Pharma plc (DEST) için kazanç
Dec 2023 itibarıyla kazanç TTM: $-8.21M
Destiny Pharma plc şirketinin en son finansal raporlarına göre, mevcut kazancı $-8.21M'dir. 2022 yılında şirket $-9.33M kazanç elde etti, bu 2021 yılındaki $-8.48M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Destiny Pharma plc için kazanç geçmişi 2013 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-8.21M 0.00%
2023 $-8.21M -12.04%
2022 $-9.33M 10.03%
2021 $-8.48M -4.31%
2020 $-8.86M 21.02%
2019 $-7.32M -4.32%
2018 $-7.65M 76.32%
2017 $-4.34M 142.61%
2016 $-1.79M 1.42%
2015 $-1.76M -45.18%
2014 $-3.22M 174.64%
2013 $-1.17M 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$5.27B -64,380.54%
US
$1.95B -23,870.85%
NL
- -
CH
- -
KR
$3.01B -36,728.02%
BE